Publications
small%20200.png?etag=%226e30-5e8edf1e%22&sourceContentType=image%2Fpng&ignoreAspectRatio&resize=300%2B54)
2024
Getting in the zone: Metabolite transport across liver zones
Stan F J van de Graaf123,Coen C Paulusma12,Wietse In Het Panhuis12
\PMID:39364668DOI:10.1111/apha.14239
Inhibition of hepatic bile salt uptake by Bulevirtide reduces atherosclerosis in Oatp1a1-/-Ldlr-/-mice
Porteiro B, Roscam Abbing RLP, In Het Panhuis W, de Waart DR, Duijst S, Bolt I, Vogels EW, Levels JHM, Bosmans LA, Vos WG, Oude Elferink RPJ, Lutgens E, van de Graaf SFJ.J
Lipid Res. 2024 Aug;65(8):100594. doi: 10.1016/j.jlr.2024.100594. Epub 2024 Jul 14.PMID:39009243
Maladaptive regeneration and metabolic dysfunction associated steatotic liver disease: Common mechanisms and potential therapeutic targets
Wu D, van de Graaf SFJ
Biochem Pharmacol. 2024 Sep;227:116437. doi: 10.1016/j.bcp.2024.116437. Epub 2024 Jul 16.PMID:39025410
Galectin-3 and prohibitin 1 are autoantigens in IgG4-related cholangitis without clear-cut protective effects against toxic bile acids
Remco Kersten # , David C Trampert # , Lowiek M Hubers, Dagmar Tolenaars, Harmjan R Vos, Stan F J van de Graaf, Ulrich Beuers
Front Immunol. 2024 Jan 25:14:1251134. doi: 10.3389/fimmu.2023.1251134. eCollection 2023.
The phospholipid flippase ATP8B1 is involved in the pathogenesis of Ulcerative Colitis via establishment of intestinal barrier function
Pim J Koelink , Valentina E Gómez-Mellado , Suzanne Duijst , Manon van Roest , Sander Meisner , Kam S Ho-Mok , Sabrina Frank , Babette S Appelman , Lysbeth Ten Bloemendaal, Georg F Vogel , Stan F J van de Graaf , Piter J Bosma , Ronald P J Oude Elferink , Manon E Wildenberg , Coen C Paulusma
J Crohns Colitis. 2024 Feb 16:jjae024. doi: 10.1093/ecco-jcc/jjae024. Online ahead of print.
Targeting bile salt homeostasis in biliary diseases
David C Trampert, Roni F Kunst, Stan F J van de Graaf
Curr Opin Gastroenterol. 2024 Mar 1;40(2):62-69. doi: 10.1097/MOG.0000000000000997. Epub 2024 Jan 10.
Targeting bile salt homeostasis in biliary diseases - PubMed (nih.gov)
Bile salt signaling and bile salt-based therapies in cardiometabolic disease
Claire C J Groenen # , Thuc-Anh Nguyen # , Coen C Paulusma , Stan F J van de Graaf
Clin Sci (Lond). 2024 Jan 10;138(1):1-21. doi: 10.1042/CS20230934.
Bile salt signaling and bile salt-based therapies in cardiometabolic disease - PubMed (nih.gov)
Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection
Trampert DC, Kersten R, Tolenaars D, Jongejan A,van de Graaf SFJ, Beuers U.
JHEP Rep. 2024 Jan 23;6(4):101015. doi: 10.1016/j.jhepr.2024.101015. eCollection 2024 Apr.PMID:38524667
Laminin 511-E8, an autoantigen in IgG4-related cholangitis, contributes to cholangiocyte protection
The Phospholipid Flippase ATP8B1 is Involved in the Pathogenesis of Ulcerative Colitis via Establishment of Intestinal Barrier Function
Koelink PJ, Gómez-Mellado VE, Duijst S, van Roest M, Meisner S, Ho-Mok KS, Frank S, Appelman BS, Bloemendaal LT, Vogel GF,van de Graaf SFJ, Bosma PJ, Oude Elferink RPJ, Wildenberg ME, Paulusma CC.J
Crohns Colitis. 2024 Aug 6;18(7):1134-1146. doi: 10.1093/ecco-jcc/jjae024.PMID:383668
2023
Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice
Roni F Kunst , Isabelle Bolt , Rychon D J van Dasselaar , Bart A Nijmeijer , Ulrich Beuers , Ronald P J Oude Elferink , Stan F J van de Graaf
JHEP Rep . 2023 Sep 25;6(1):100917. doi: 10.1016/j.jhepr.2023.100917. eCollection 2024 Jan.
IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathies
Remco Kersten David C Trampert, Toni Herta, Lowiek M Hubers, Lucas J Maillette de Buy Wenniger, Joanne Verheij, Stan F J van de Graaf, Ulrich Beuers
J Hepato. 2023 Dec;79(6):1502-1523.doi: 10.1016/j.jhep.2023.08.005. Epub 2023 Aug 18.
IgG4-related cholangitis - a mimicker of fibrosing and malignant cholangiopathies - PubMed (nih.gov)
Bile Salts by the Back Road
Ronald P J Oude Elferink Stan F J Van De Graaf
Cell Mol Gastroenterol Hepatol. 2023;16(2):319-320. doi: 10.1016/j.jcmgh.2023.05.005. Epub 2023 May 24.
Bile Salts by the Back Road - PubMed (nih.gov)
Intestinal Bacteremia After Liver Transplantation Is a Risk Factor for Recurrence of Primary Sclerosing Cholangitis
Ruslan A Mammadov , Jasmijn W Selten, Henk P Roest, Cornelia J Verhoeven , Luca Maroni, Sandra I Bril, Dagmar Tolenaars, Pravesh S Gadjradj, Stan F J van de Graaf Ronald P J Oude Elferink, Jaap Kwekkeboom, Herold J Metselaar, Maikel P Peppelenbosch, Ulrich Beuers, Jan N M IJzermans, Luc J W van der Laan
2022
Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection
Herta T, Kersten R, Chang JC, Hubers L, Go S, Tolenaars D, Paulusma CC, Nathanson MH, Elferink RO,van de Graaf SFJ, Beuers U
J Hepatol. 2022 Feb;76(2):319-331. doi: 10.1016/j.jhep.2021.10.009. Epub 2021 Oct 27.PMID:34718050
Amino acid metabolism, transport and signalling in the liver revisited
Paulusma CC, Lamers WH, Broer S,van de Graaf SFJ.
Biochem Pharmacol. 2022 Jul;201:115074. doi: 10.1016/j.bcp.2022.115074. Epub 2022 May 11.PMID:35568239
Amino acid metabolism, transport and signalling in the liver revisited - PubMed (nih.gov)
Systemic ASBT inactivation protects against liver damage in obstructive cholestasis in mice
Kunst RF, de Waart DR, Wolters F, Duijst S, Vogels EW, Bolt I, Verheij J, Beuers U, Oude Elferink RPJ,van de Graaf SFJ
JHEP Rep. 2022 Aug 27;4(11):100573. doi: 10.1016/j.jhepr.2022.100573. eCollection 2022 Nov.PMID:36160754
Differential and organ-specific functions of organic solute transporter α and β in experimental cholestasis
van de Wiel SMW, Porteiro B, Belt SC, Vogels EWM, Bolt I, Vermeulen JLM, de Waart DR, Verheij J, Muncan V, Oude Elferink RPJ,van de Graaf SFJ.
JHEP Rep.2022 Mar 5;4(5):100463.doi: 10.1016/j.jhepr.2022.100463.
2021
Trampert DC, van de Graaf SFJ, Jongejan A, Oude Elferink RPJ, Beuers U.
J Hepatol. 2021 Aug;75(2):497. doi: 10.1016/j.jhep.2021.05.002. Epub 2021 May 13.PMID: 33991636
Langedijk JAGM, Tolenaars D, Bolier R, Lee YT, Meurs A, Williamson C, Adorini L, van de Graaf SFJ, Beuers U, Elferink RO.
Biochim Biophys Acta Mol Basis Dis. 2021 Nov 1;1867(11):166239. doi: 10.1016/j.bbadis.2021.166239. Epub 2021 Aug 10.PMID: 34389475
Zaufel A, van de Wiel SMW, Yin L, Fauler G, Chien D, Dong X, Gilmer JF, Truong JK, Dawson PA, van de Graaf SFJ, Fickert P, Moustafa T.
Biochim Biophys Acta Mol Basis Dis. 2021 Aug 1;1867(8):166153. doi: 10.1016/j.bbadis.2021.166153. Epub 2021 Apr 22.PMID: 33895309
Applicability of different cell line-derived dendritic cell-like cells in autophagy research.
Prins MMC, van Roest M, Vermeulen JLM, Tjabringa GS, van de Graaf SFJ, Koelink PJ, Wildenberg ME.
J Immunol Methods. 2021 Oct;497:113106. doi: 10.1016/j.jim.2021.113106. Epub 2021 Jul 26.PMID: 34324891
Kunst RF, Verkade HJ, Oude Elferink RPJ, van de Graaf SFJ.
Hepatology. 2021 Jun;73(6):2577-2585. doi: 10.1002/hep.31651. Epub 2021 May 24.PMID: 33222321
Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP.
Appelman MD, Wettengel JM, Protzer U, Oude Elferink RPJ, van de Graaf SFJ
Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Aug;1866(8):158960. doi: 10.1016/j.bbalip.2021.158960. Epub 2021 Apr 29.PMID: 33932583
Hepatobiliary acid-base homeostasis: Insights from analogous secretory epithelia
Trampert DC, van de Graaf SFJ, Jongejan A, Oude Elferink RPJ, Beuers U.
J Hepatol. 2021 Feb;74(2):428-441. doi: 10.1016/j.jhep.2020.10.010. PMID: 33342564.
2020
Targeting the four pillars of enterohepatic bile salt cycling; lessons from genetics and pharmacology.
Kunst RF, Verkade HJ, Oude Elferink RPJ, van de Graaf SFJ.
Hepatology. 2020 doi: 10.1002/hep.31651. PMID: 33222321.
An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective
spf/ash Mouse Model of Ornithine Transcarbamylase Deficiency.
Balestra D, Ferrarese M, Lombardi S, Ziliotto N, Branchini A, Petersen N, Bosma P, Pinotti M, van de Graaf SFJ.
Int J Mol Sci. 2020 ;21(22):8735. doi: 10.3390/ijms21228735. PMID: 33228018
From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and
disease.Kunst RF, Niemeijer M, van der Laan LJW, Spee B, van de Graaf SFJ.
Biochem Pharmacol. 2020;180:114173. doi: 10.1016/j.bcp.2020.114173.PMID: 32717228.
Inhibition of Hepatic Bile Acid Uptake by Myrcludex B Promotes Glucagon-Like Peptide-1 Release and Reduces Obesity.
Donkers JM, Roscam Abbing RLP, van Weeghel M, Levels JHM, Boelen A, Schinkel
AH, Oude Elferink RPJ, van de Graaf SFJ.
Cell Mol Gastroenterol Hepatol. 2020;10(3):451-466. doi:
10.1016/j.jcmgh.2020.04.009. Epub 2020 Apr 21. PMID: 32330730
Blocking sodium-taurocholate cotransporting polypeptide stimulates biliary cholesterol and phospholipid secretion.
Roscam Abbing RLP, Slijepcevic D, Donkers JM, Havinga R, Duijst S, Paulusma CC, Kuiper J, Kuipers F, Groen AK, Oude Elferink RPJ and Van de Graaf SFJ.
Hepatology, 2020 Jan;71(1):247-258. PMID: 31136002
The Lipid Raft Component Stomatin Interacts with the Na+ Taurocholate Cotransporting Polypeptide (NTCP) and Modulates Bile Salt Uptake.
Appelman MD, Robin MJD, Vogels EWM, Wolzak C, Vos WG, Vos HR, Van Es RM, Burgering BMT, Van de Graaf SFJ.
Cells. 2020 Apr 16;9(4):986. doi: 10.3390/cells9040986.PMID: 32316189
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I.
Balestra D, Scalet D, Ferrarese M, Lombardi S, Ziliotto N, C Croes C, Petersen N, Bosma P, Riccardi F, Pagani F, Pinotti M, van de Graaf SFJ.
Int J Mol Sci. 2020 Mar 20;21(6):2136. doi: 10.3390/ijms21062136. PMID: 32244944
2019
FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-κB-RIPK1-caspase axis
Qu C, Li Y, Li Y, Yu P, Li P, Donkers JM, Van de Graaf SFJ, de Man RA, Peppelenbosch MP, Pan Q.
Antiviral Res. 2019 Oct;170:104588. PMID: 31415805
Mechanistic insights to the inhibition of NTCP by Myrcludex B
Joanne M. Donkers, Monique D. Appelman and Stan F.J. van de Graaf.
Journal Of Hepatology Reports, 2019 Aug 1;1(4):278-285. PMID: 32039379
NTCP deficiency in mice protects against obesity and hepatosteatosis
Donkers JM, Kooijman S, Slijepcevic D, Kunst R, Roscam Abbing RLP, Haazen L, De Waart DR, Levels JHM, Schoonjans K, Rensen PCN, Oude Elferink RPJ and Van de Graaf SFJ.
JCI Insight, 2019. doi: 10.1172/jci.insight.127197. PMID: 31237863
Developments in bile salt based therapies: A critical overview.
Donkers JM, Roscam Abbing RLP, Van de Graaf SFJ. PMID: 30582898
Biochemical Pharmacology. 2019 Mar;161:1-13
Identification of FDA-approved drugs targeting the Farnesoid X Receptor
Van de Wiel SMW, Bijsmans ITGW, Van Mil SWC, Van de Graaf SFJ.
Sci Rep. 2019 Feb 18;9(1):2193. PMID: 30778102
2018
Calnexin depletion by ER-stress during cholestasis inhibits the Na+-taurocholate Cotransporting Polypeptide (NTCP)
Robin MJD, Monique D. Appelman MD, Vos HR, Van Es RM, Paton JC, Paton AW, Burgering B, Fickert P, Heijmans J, Van de Graaf SFJ. Hepatology Communications, 2018 Oct 23;2(12):1550-1566. PMID: 30556041
The case for combining treatments for primary sclerosing cholangitis
Roscam Abbing RLP, de Lannoy LM, van de Graaf SFJ.
Lancet Gastroenterol Hepatol. 2018 Aug;3(8):526-528. PMID: 30047442
Na+ -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice
Slijepcevic D, Roscam Abbing RLP, Fuchs CD, Haazen LCM, Beuers U, Trauner M, Oude Elferink RPJ, Van de Graaf SFJ.
Hepatology. 2018, 68: 3, p.1057-1069. PMID: 29572910
Bioengineered bile ducts recapitulate key cholangiocyte functions
Chen C, Jochems PGM, Salz L, Schneeberger K, Penning LC, van de Graaf SFJ, Beuers U, Clevers H, Geijsen N, Masereeuw R, Spee B. Biofabrication. 2018 Jun 12;10(3):034103. PMID: 29848792
The somatic FAH C.1061C>A change counteracts the frequent FAH c.1062+5G>A mutation and permits U1snRNA-based splicing correction.
Scalet D, Sacchetto C, Bernardi F, Pinotti M, Van de Graaf SFJ, Balestra D.
J Hum Genet. 2018 May;63(5):683-686. PMID: 29497141
Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease
Hubers LM, Vos H, Schuurman AR, Erken R, Oude Elferink RP, Burgering B, van de Graaf SFJ*, Beuers U*.
Gut. 2018 Apr;67(4):728-735. PMID: 28765476
On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease
Trampert DC, Hubers LM, Van de Graaf SF, Beuers U.
BBA - Molecular Basis of Disease, 2018 Apr;1864(4 Pt B):1401-1409. PMID: 28782655
The NTCP - inhibitor myrcludex B: Effects on bile acid disposition and tenofovir pharmacokinetics
Blank A, Eidam A, Haag M, Hohmann N, Burhenne J, Schwab M, Van de Graaf S, Meyer MR, Maurer HH, Meier K, Weiss J, Bruckner T, Alexandrov A, Urban S, Mikus G, Haefeli WE.
Clin Pharmacol Ther. 2018 Feb;103(2):341-348. PMID: 28543042
2017
Role of the Bile Acid Transporter SLC10A1 in Liver Targeting of the Lipid-Lowering Thyroid Hormone Analog Eprotirome
Kersseboom S, van Gucht ALM, van Mullem A, Brigante G, Farina S, Carlsson B, Donkers JM, van de Graaf SFJ, Peeters RP, Visser TJ.
Endocrinology. 2017 Oct 1;158(10):3307-3318. PMID: 28938430
Biliverdin Reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo
van Dijk R, Aronson SJ, de Waart DR, van de Graaf SF, Duijst S, Seppen J, Elferink RO, Beuers U, Bosma PJ.
Sci Rep. 2017 May 10;7(1):1646. PMID: 28490767
Current and future therapies for inherited cholestatic liver diseases
van der Woerd WL, Houwen RH, van de Graaf SF.
World J Gastroenterol. 2017 Feb 7;23(5):763-775. doi: 10.3748/wjg.v23.i5.763. Review. PMID: 28223721 / PMCID: 2596193
N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection
Appelman MD, Chakraborty A, Protzer U, McKeating JA, van de Graaf SF.
PLoS One. 2017 Jan 26;12(1):e0170419. doi: 10.1371/journal.pone.0170419. PMID: 28125599
Knockout of the Primary Sclerosing Cholangitis-Risk Gene Fut2 Causes Liver Disease in Mice
Maroni L, Hohenester SD, van de Graaf SF, Tolenaars D, van Lienden K, Verheij J, Marzioni M, Karlsen TH, Oude Elferink RP, Beuers U.
Hepatology. 2017 Jan 5. doi: 10.1002/hep.29029. [Epub ahead of print] PMID: 28056490
Bile Acid Uptake Transporters as Targets for Therapy
Slijepcevic D, van de Graaf SF.
Dig Dis. 2017;35(3):251-258. doi: 10.1159/000450983. PMID: 28249291
Hepatic uptake of conjugated bile acids is mediated by both NTCP and OATPs and modulated by intestinal sensing of plasma bile acid levels in mice
Slijepcevic D, Roscam Abbing RLP, Katafuchi T, Blank A, Donkers JM, van Hoppe S, de Waart DR, Tolenaars D, van der Meer JHM, Wildenberg M, Beuers U, Oude Elferink RPJ, Schinkel AH, Van de Graaf SF.
Hepatology. 2017 Nov;66(5):1631-1643 (see also Hepatology. 2018 Mar;67(3):1185-1186). PMID: 28498614
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP
Joanne M. Donkers, Benno Zehnder, Gerard J. P. van Westen, Mark J. Kwakkenbos,Adriaan P. IJzerman, Ronald P. J. Oude Elferink, Ulrich Beuers, Stephan Urban & Stan F. J. van de Graaf
Scientific Reports | 7: 15307 | DOI:10.1038/s41598-017-15338-0. PMID: 29127322
Intestinal FXR activation by pharmacological inhibition of the organic solute transporter α-β
Sandra M.W. van de Wiel, D. Rudi de Waart, Ronald P.J. Oude Elferink and Stan F.J. van de Graaf.
Cellular and Molecular Gastroenterology and Hepatology, 2017 Nov 28;5(3):223-237. PMID: 29675448 / PMCID: 5904037
2016
Immunoglobulin G4+ B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies
Doorenspleet ME, Hubers LM, Culver EL, Maillette de Buy Wenniger LJ, Klarenbeek PL, Chapman RW, Baas F, van de Graaf SF, Verheij J, van Gulik TM, Barnes E, Beuers U, de Vries N.
Hepatology. 2016;64(2):501-7. doi: 10.1002/hep.28568. PMID: 27015613
Rescue of defective ATP8B1 trafficking by CFTR correctors as a therapeutic strategy for familial intrahepatic cholestasis
Van der Woerd WL, Wichers CG, Vestergaard AL, Andersen JP, Paulusma CC, Houwen RH, van de Graaf SF.
J Hepatol. 2016;64(6):1339-47. doi: 10.1016/j.jhep.2016.02.001. PMID: 26879107
Real Time Monitoring of Intracellular Bile Acid Dynamics Using a Genetically Encoded FRET-based Bile Acid Sensor
Sandra Van de Wiel, Maarten Merkx and Stan van de Graaf
Journal of Visualized Experiments, JoVE (http://www.jove.com/video/53659)
2015
ATP8B1-mediated spatial organization of Cdc42 signaling maintains singularity during enterocyte polarization.
Bruurs LJ, Donker L, Zwakenberg S, Zwartkruis FJ, Begthel H, Knisely AS, Posthuma G, van de Graaf SF, Paulusma CC, Bos JL.
J Cell Biol. 2015 Sep 28;210(7):1055-63. PMID: 26416959
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in Na(+) -taurocholate cotransporting polypeptide knockout mice
Slijepcevic D, Kaufman C, Wichers CG, Gilglioni EH, Lempp FA, Duijst S, de Waart DR, Oude Elferink RP, Mier W, Stieger B, Beuers U, Urban S, Van de Graaf SF.
Hepatology. 2015 Jul;62(1):207-19] PubMed PMID: 25641256.
Analysis of aberrant pre-messenger RNA splicing resulting from mutations in ATP8B1 and efficient in vitro rescue by adapted U1 small nuclear RNA
Van der Woerd WL, Mulder J, Pagani F, Beuers U, Houwen RH, Van de Graaf SF.
Hepatology. 2015 Apr;61(4):1382-91. doi: 10.1002/hep.27620. Epub 2015 Feb 23. PubMed PMID: 25421123.
IgG4-Associated Cholangitis: A Comprehensive Review
Hubers LM, Maillette de Buy Wenniger LJ, Doorenspleet ME, Klarenbeek PL, Verheij J, Rauws EA, Van Gulik TM, Oude Elferink RP, Van de Graaf SF, de Vries N, Beuers U.
Clin Rev Allergy Immunol. 2015 Jun;48(2-3):198-206. doi: 10.1007/s12016-014-8430-2. PubMed PMID: 24958363
Fucosyltransferase 2: a genetic risk factor for primary sclerosing cholangitis and Crohn's disease-a comprehensive review
Maroni L, Van de Graaf SF, Hohenester SD, Oude Elferink RP, Beuers U. .
Clin Rev Allergy Immunol. 2015 Jun;48(2-3):182-91. doi: 10.1007/s12016-014-8423-1. PubMed PMID: 24828903.
2014
Quantifying stickiness: thermodynamic characterization of intramolecular domain interactions to guide the design of förster resonance energy transfer sensors
Lindenburg LH, Malisauskas M, Sips T, Van Oppen L, Wijnands SP, Van de Graaf SF, Merkx M.
Biochemistry. 2014 Oct 14;53(40):6370-81. doi: 10.1021/bi500433j. Epub 2014 Sep 26. PubMed PMID: 25216081
IgG4-associated cholangitis
Beuers U, Maillette de Buy Wenniger LJ, Doorenspleet M, Hubers L, Verheij J, Van Gulik T, Van de Graaf SF, de Vries N.
Dig Dis. 2014;32(5):605-8. doi: 10.1159/000360513. Epub 2014 Jul 14. Review. PubMed PMID: 25034294
Autophagy - another piece of the puzzle towards understanding primary biliary cirrhosis?
Van de Graaf S, Beuers U.
Liver Int. 2014 Apr;34(4):481-3. doi: 10.1111/liv.12357. No abstract available. PMID: 24612169
2013
Mutational analysis of ATP8B1 in patients with chronic pancreatitis
Van der Woerd WL, Van Haaften-Visser DY, Van de Graaf SF, Férec C, Masson E, Stapelbroek JM, Bugert P, Witt H, Houwen RH.
PLoS One. 2013 Nov 19;8(11):e80553. doi: 10.1371/journal.pone.0080553. eCollection 2013. PubMed PMID: 24260417; PubMed Central PMCID: PMC3834041.
Early adipogenesis is regulated through USP7-mediated deubiquitination of the histone acetyltransferase TIP60
Gao Y, Koppen A, Rakhshandehroo M, Tasdelen I, Van de Graaf SF, Van Loosdregt J, Van Beekum O, Hamers N, Van Leenen D, Berkers CR, Berger R, Holstege FC, Coffer PJ, Brenkman AB, Ovaa H, Kalkhoven E.
Nat Commun. 2013;4:2656. doi: 10.1038/ncomms3656. PubMed PMID: 24141283
Monitoring bile acid transport in single living cells using a genetically encoded Förster resonance energy transfer sensor
Van der Velden LM, Golynskiy MV, Bijsmans IT, Van Mil SW, Klomp LW, Merkx M, Van de Graaf SF.
Hepatology. 2013 Feb;57(2):740-52. doi: 10.1002/hep.26012. Epub 2013 Jan 8. PubMed PMID: 22899095
2012
Natural killer T cells in adipose tissue prevent insulin resistance
Schipper HS, Rakhshandehroo M, Van de Graaf SF, Venken K, Koppen A, Stienstra R, Prop S, Meerding J, Hamers N, Besra G, Boon L, Nieuwenhuis EE, Elewaut D, Prakken B, Kersten S, Boes M, Kalkhoven E.
J Clin Invest. 2012 Sep;122(9):3343-54. doi: 10.1172/JCI62739. Epub 2012 Aug 6. PubMed PMID: 22863618; PubMed Central PMCID:
PMC3428087.
Homo- and hetero-dimeric architecture of the human liver Na⁺-dependent taurocholate co-transporting protein
Bijsmans IT, Bouwmeester RA, Geyer J, Faber KN, Van de Graaf SF.
Biochem J. 2012 Feb 1;441(3):1007-15. doi: 10.1042/BJ20111234. PubMed PMID: 22029531
2010
Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy
Van der Woerd WL, Van Mil SW, Stapelbroek JM, Klomp LW, Van de Graaf SF, Houwen RH.
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):541-53. doi: 10.1016/j.bpg.2010.07.010. Review. PubMed PMID: 20955958
Heteromeric interactions required for abundance and subcellular localization of human CDC50 proteins and class 1 P4-ATPases
Van der Velden LM, Wichers CG, Van Breevoort AE, Coleman JA, Molday RS, Berger R, Klomp LW, Van de Graaf SF.
J Biol Chem. 2010 Dec 17;285(51):40088-96. doi: 10.1074/jbc.M110.139006. Epub 2010 Oct 14. PubMed PMID: 20947505; PubMed Central PMCID: PMC3000991.
Biochemical and cellular functions of P4 ATPases
Van der Velden LM, Van de Graaf SF, Klomp LW.
Biochem J. 2010 Oct 1;431(1):1-11. doi: 10.1042/BJ20100644. Review. PubMed PMID: 20836764
Folding defects in P-type ATP 8B1 associated with hereditary cholestasis are ameliorated by 4-phenylbutyrate
Van der Velden LM, Stapelbroek JM, Krieger E, Van den Berghe PV, Berger R, Verhulst PM, Holthuis JC, Houwen RH, Klomp LW, Van de Graaf SF.
Hepatology. 2010 Jan;51(1):286-96. doi: 10.1002/hep.23268. PubMed PMID: 19918981
2009
Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin
Van den Berghe PV, Stapelbroek JM, Krieger E, de Bie P, Van de Graaf SF, de Groot RE, Van Beurden E, Spijker E, Houwen RH, Berger R, Klomp LW.
Hepatology. 2009 Dec;50(6):1783-95. doi: 10.1002/hep.23209. PubMed PMID: 19937698
Conditional fast expression and function of multimeric TRPV5 channels using Shield-1
Schoeber JP, Van de Graaf SF, Lee KP, Wittgen HG, Hoenderop JG, Bindels RJ.
Am J Physiol Renal Physiol. 2009 Jan;296(1):F204-11. doi: 10.1152/ajprenal.90473.2008. Epub 2008 Oct 8. PubMed PMID: 18842822
2008 and before
Van de Graaf SF, Rescher U, Hoenderop JG, Verkaart S, Bindels RJ, Gerke V. TRPV5 is internalized via clathrin-dependent endocytosis to enter a Ca2+-controlled recycling pathway. J Biol Chem. 2008 Feb 15;283(7):4077-86. Epub 2007 Dec 12. PubMed PMID: 18077461.
Van de Graaf SF, Bindels RJ, Hoenderop JG. Physiology of epithelial Ca2+ and Mg2+ transport. Rev Physiol Biochem Pharmacol. 2007;158:77-160. Review. PubMed PMID: 17729442.
Van de Graaf SF, Hoenderop JG, Bindels RJ. Regulation of TRPV5 and TRPV6 by associated proteins. Am J Physiol Renal Physiol. 2006 Jun;290(6):F1295-302. Review. PubMed PMID: 16682485.
Van de Graaf SF, Hoenderop JG, Van der Kemp AW, Gisler SM, Bindels RJ. Interaction of the epithelial Ca2+ channels TRPV5 and TRPV6 with the intestine-and kidney-enriched PDZ protein NHERF4. Pflugers Arch. 2006 Jul;452(4):407-17. Epub 2006 Mar 25. PubMed PMID: 16565876.
Van de Graaf SF, Van der Kemp AW, Van den Berg D, Van Oorschot M, HoenderopJG, Bindels RJ. Identification of BSPRY as a novel auxiliary protein inhibiting TRPV5 activity. J Am Soc Nephrol. 2006 Jan;17(1):26-30. PubMed PMID: 16380433.
Van de Graaf SF, Chang Q, Mensenkamp AR, Hoenderop JG, Bindels RJ. Direct interaction with Rab11a targets the epithelial Ca2+ channels TRPV5 and TRPV6 to the plasma membrane. Mol Cell Biol. 2006 Jan;26(1):303-12. PubMed PMID: 16354700; PubMed Central PMCID: PMC1317621.
den Dekker E, Schoeber J, Topala CN, Van de Graaf SF, Hoenderop JG, Bindels RJ. Characterization of a Madin-Darby canine kidney cell line stably expressing TRPV5. Pflugers Arch. 2005 Jul;450(4):236-44. Epub 2005 May 28. PubMed PMID: 15924239.
Palmada M, Poppendieck S, Embark HM, Van de Graaf SF, Boehmer C, Bindels RJ, Lang F. Requirement of PDZ domains for the stimulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating factor NHERF2 and the serum and glucocorticoid inducible kinase SGK1. Cell Physiol Biochem. 2005;15(1-4):175-82. PubMed PMID: 15665527.
Chang Q, Gyftogianni E, Van de Graaf SF, Hoefs S, Weidema FA, Bindels RJ, Hoenderop JG. Molecular determinants in TRPV5 channel assembly. J Biol Chem. 2004 Dec 24;279(52):54304-11. Epub 2004 Oct 15. PubMed PMID: 15489237.
Embark HM, Setiawan I, Poppendieck S, Van de Graaf SF, Boehmer C, Palmada M, Wieder T, Gerstberger R, Cohen P, Yun CC, Bindels RJ, Lang F. Regulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating factor NHERF2 and the serum and glucocorticoid inducible kinase isoforms SGK1 and SGK3 expressed in Xenopus oocytes. Cell Physiol Biochem. 2004;14(4-6):203-12. PubMed PMID: 15319523.
Van de Graaf SF, Boullart I, Hoenderop JG, Bindels RJ. Regulation of the epithelial Ca2+ channels TRPV5 and TRPV6 by 1alpha,25-dihydroxy Vitamin D3 and dietary Ca2+. J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):303-8. Review. PubMed PMID: 15225790.
Van de Graaf SF, Hoenderop JG, Gkika D, Lamers D, Prenen J, Rescher U, Gerke V, Staub O, Nilius B, Bindels RJ. Functional expression of the epithelial Ca2+ channels (TRPV5 and TRPV6) requires association of the S100A10-annexin 2 complex. EMBO J. 2003 Apr 1;22(7):1478-87. PubMed PMID: 12660155; PubMed Central PMCID: PMC152906.
Danahay H, Withey L, Poll CT, Van de Graaf SF, Bridges RJ. Protease-activated receptor-2-mediated inhibition of ion transport in human bronchial epithelial cells. Am J Physiol Cell Physiol. 2001 Jun;280(6):C1455-64. PubMed PMID:11350741.
Hoenderop JG, Van der Kemp AW, Hartog A, Van de Graaf SF, Van Os CH, Willems PH, Bindels RJ. Molecular identification of the apical Ca2+ channel in 1,25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem. 1999 Mar26;274(13):8375-8. PubMed PMID: 10085067.